Turbine

🏙️ Turbine will be exhibiting at BIO-Europe Fall, November 3–5, 2025 in Vienna! 🙋♂️ Meet members of our Business Development team, Balázs Horváth (Associate) and Pier Giorgio Pacifici, Ph.D. (Director), at booth C 198 in the Vienna Congress and Convention Center. Attendees are invited to experience our Virtual Lab on-site, to see how simulated experiments accelerate workflows and decision-making in R&D! Interested? Connect with our team in the exhibit hall, even during the evening reception! See you in Vienna! #BIOEurope #VirtualLab #Biotech #Vienna2025 #virtualdrugdiscovery #decodingbiology #simulatedcell #virtualizeexperiments #virtualcell #aiforbiology

🏙️ Turbine is heading to World ADC San Diego from November 3–6, 2025! 💊💊 Our team will be presenting new research on dual ADC payload synergy, leveraging Turbine’s Simulated Cell Platform and automated wet lab. Meet our team on-site: Louisa Roberts – Chief Business Officer Neeraj Rao – Business Development Director Akos Tarcsay – Product Manager Jerzy Woźnicki, PhD – Scientific Project Lead Bálint Paholcsek – Head of MarCom Don’t miss Jerzy's 15-minute talk about our poster and technology (November 5, 12:45pm). If you’d like to connect, reach out directly to any of our team members. See you in San Diego! #WorldADC #ADC #virtuallab #OncologyResearch #virtualdrugdiscovery #decodingbiology #simulatedcell #labautomation #virtualizeexperiments #antibodydrugconjugates #aiforbiology

🏙️ Our team is heading to ESMO - European Society for Medical Oncology Congress 2025 in Berlin (October 17-21) Looking to explore collaborations or learn more about our 🖥️🔬 Virtual Lab platform? Reach out to any of our team members directly. Szabolcs Nagy - CEO & Co-founder Daniel Veres MD PhD - CSO & Co-founder Krishna C Bulusu - VP of Product Innovation & Strategy Tamás Miklós Török - Head of Business Development István Taisz - Scientific Project Manager Luca Bárdió - PR & Storytelling See you in Berlin. #ESMO2025 #oncologyresearch #drugdiscovery #computationalbiology #virtualdrugdiscovery #decodingbiology #simulatedcell #aiforbiology #virtualizeexperiments

Fierce Biotech summed up our joint mission with AstraZeneca well: rationalizing ADC discovery by creating a simulate-test-learn cycle that helps scientists focus on the experiments that matter most. For us, this is all about making simulations an essential part of the pharma R&D workflow, giving every scientist the ability to test virtually all hypotheses and explore only what truly matters in the wet lab. This collaboration with AstraZeneca is a leap toward that vision. 🚀 Read more here: https://lnkd.in/d2a6fUXx

We’re thrilled to announce our new ADC collaboration with AstraZeneca!🚀 While this isn’t our first collaboration, it’s our kick-off focused on ADCs, an exciting new chapter in our partnership. Together, we’ll apply Turbine’s virtual disease models to accelerate and rationalize antibody-drug conjugate (ADC) discovery by predicting response mechanisms, improving positioning, and reducing the need for large-scale experimental screening. By combining AstraZeneca’s world-class oncology expertise with Turbine’s simulations, we’re building a simulate-test-learn cycle that lets scientists iterate faster and focus on the experiments that truly matter. 💥Check out the full press release below for more details: https://lnkd.in/dbhVnyAs #ADC #Collaboration #DrugDiscovery #Oncology #Turbine #AstraZeneca

🤝Let’s connect at BioTechX next week! Pier Giorgio Pacifici, Ph.D., our Business Development Director, and Szabolcs Nagy, Co-founder & CEO, will be there. On Monday, 6 October at 17:25 in Theatre 10, Szabi also will join the panel “How AI Models Are Being Used in Clinical Trials: Optimizing Trial Design and Accelerating Readouts by 12+ months”, alongside with Rafael Rosengarten (Alliance for Artificial Intelligence in Healthcare), Felix Baldauf-Lenschen (Altis Labs), Mustaqhusain Kazi (Genentech) and Joseph Pearson (QIAGEN). At Turbine, we’re virtualizing biological experiments with AI to accelerate discovery and enhance clinical translation - helping scientists run millions of experiments in silico and bring smarter therapies to patients faster. Let’s talk about how.

We’re excited to join the Memorial Sloan Kettering Cancer Center (MSK) iHub Challenge 2025 Cohort Program alongside fellow innovators 4baseCare, Standard Model Biomedicine, StratifAI, and Synteny. Through our collaboration with MSK, we now gain access to a robust patient dataset - an exciting foundation for improving and validating our virtual cell models to accelerate drug discovery and enhance clinical translatability. We can’t wait to continue this journey in the program and we’re glad our colleagues Krishna C Bulusu and László Mérő were in New York for the kickoff event to experience it firsthand. Learn more about the program here: https://bit.ly/426PahJ

🚀We’re excited to welcome Krishna C Bulusu as our new Vice President of Product Strategy & Innovation! Krishna brings over a decade of experience at the intersection of AI, computational biology, and drug discovery. Most recently, at AstraZeneca, he led the Knowledge Graphs & ADC Discovery team in Oncology Data Science & AI driving innovative approaches to accelerate drug discovery from target identification to patient stratification. His work has also focused on building collaborations across academia, startups, and industry to democratize the impact of AI in healthcare. With his proven track record, in scientific innovation, knowledge graphs, and virtual biology, Krishna is a recognized leader and mentor who knows how to translate cutting-edge science into real-world impact. We’re thrilled to have him join us to shape our product strategy and innovation as we continue building the future of drug discovery, where virtual biological experiments guide the path from lab to clinic, helping deliver medicine to patients who need it the most. Please join us in giving Krishna a warm welcome! 👏

🇺🇸 Want to know how AI learns, see a virtual lab in action, or clear up myths about sweeteners and red meat? 🍖🤖🔬 Drop by Turbine at Researchers’ Night for interactive science talks and digital experiments, including an English-language session! Join us on September 26, 2025 at 1083 Budapest, Szigony u. 26–32. --- 🇭🇺 Érdekel, hogyan tanul a mesterséges intelligencia, vagy kíváncsi vagy egy virtuális laborra, ahol nincs kémcső, csak szimuláció? 🍖🤖🔬 Gyere el a Turbine-hoz a Kutatók Éjszakáján, ahol tudományos beszélgetések, digitális kísérletek és angol nyelvű előadás is vár! Találkozzunk 2025. szeptember 26-án a 1083 Budapest, Szigony u. 26–32 címen. 👉 Program info: https://lnkd.in/dWu7uqqf #ResearchersNight #Budapest #ScienceMatters #LifeScience #MLresearch #OpenLaboratory #Turbine #KutatókÉjszakája

In a recent Drug Discovery News piece, our Co-Founder & CSO Daniel Veres MD PhD spoke about virtual models: 👉Where they work best: preclinical research. Testing dosing schedules, biomarker strategies, and exposure-response relationships before patient health is on the line makes studies smarter and more likely to translate to clinic. 👉What’s still a challenge: robustness, practical scalability, and let’s be real - the trust gap. Building confidence in predictions is just as critical as advancing the tech. Turbine is building virtual disease models that aren’t merely science projects, but putting cutting-edge tools put into scientists’ hands they can trust and actually use today. Read the full piece here: https://lnkd.in/ddt3xnaD